Autolus Therapeutics plc (AUTL) Net margin 2016–2025
Autolus Therapeutics plc (AUTL) net profit margin by fiscal year — reported net income divided by reported revenue.
-381.4%FY2025 · since FY2016: -1035.5% → -381.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -381.4% | +1799.1 pp |
| FY2024 | -2180.5% | +10091.8 pp |
| FY2023 | -12272.3% | — |
| FY2019 | -4258.9% | -1078.3 pp |
| FY2018 | -3180.6% | -2015.4 pp |
| FY2017 | -1165.2% | -129.7 pp |
| FY2016 | -1035.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Operating cash flowAUTL Free cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →